NINDS has stopped the combination antiplatelet intervention in the Secondary Prevention of Small Subcortical Strokes (SPS3) trial. This was a randomized, multicenter clinical trial conducted throughout North America, Latin America and Spain, to learn about preventing a second stroke in patients who had a subcortical stroke and to learn how to prevent cognitive problems after a stroke. Visit the NLM website for further information about the trial.

This entry was posted on Tuesday, September 20th, 2011 at 8:59 am and is filed under Clinical Trials. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.